Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment

Key Inclusion Criteria:

- Male and female subjects aged 18 to 70 years, with hepatic impairment conforming to
Child-Pugh class A, B or C

- Healthy subjects to the extent possible matched to the first four hepatically
impaired subject in each Child-Pugh class with regard to age (approximately ± 10
years), body weight (approximately ± 20%) and gender

Key Exclusion Criteria:

- History of esophageal and gastric variceal bleeding within past 6 months

- Primarily cholestatic liver diseases

- Active alcoholic hepatitis

- Stable encephalopathy of >= Stage 2

- Presence of severe ascites or edema

- Presence of hepatopulmonary or hepatorenal syndrome

- Positive for HCV, unless HCV RNA is undetectable